Analyst Report: BE
1. EXECUTIVE SUMMARY
Bloom Energy closed at $263.45 on Tuesday, down 10.93% from $295.78 on 6 October, after two large down sessions on 8 October (-6.34%) and 12 October (-6.50%) and a small rebound of 0.45% on 13 October. The brief attributes the 8 October fall to a broad selloff in high-valuation AI and data-center power names, which Benzinga linked to a 10-year Treasury yield of 5.35% and Fed-hike worries (a single-source attribution). The 12 October fall was tied by Investing.com and TradingKey to de-risking before the Q3 report, unresolved concentration risk in Oracle's Project Jupiter, and a valuation premium to consensus targets. The S&P 500 slipped 0.17% over the same period, so the weakness belongs to the stock and its peer group. Q3 results on 22 October after the close are the next test, with gross margin the figure Trefis flags as key.
2. THE CATALYST
No single company announcement caused the decline. The sessions break down as follows.
| Session | Close | Change | Driver in the brief |
|---|---|---|---|
| 7 Oct | $291.29 | -1.52% | UBS (Manav Gupta) kept Buy and raised its target from $325 to $350 (MarketBeat) |
| 8 Oct | $272.82 | -6.34% | Selloff in high-valuation AI and data-center power names; 10-year yield touched 5.35% (Benzinga) |
| 9 Oct | $280.50 | +2.82% | No catalyst in the brief |
| 12 Oct | $262.28 | -6.50% | Pre-earnings de-risking, Project Jupiter concentration, valuation above consensus targets (Investing.com); profit-taking (TradingKey) |
| 13 Oct | $263.45 | +0.45% | Oracle proposed an energy service agreement with El Paso Electric and said Bloom remains the primary power source (Stocktwits) |
On 8 October, 24/7 Wall St. reported that FuelCell Energy fell about 8% and Plug Power about 3%, even though UBS had lifted its target that day. The Benzinga explanation rests on one article, and the brief found no second source for it. The brief also notes that TradingKey reports a larger intraday drop than the close on 12 October, so its figures are left aside here.
Bloom confirmed on 12 October that Q3 results arrive on 22 October after the close (Business Wire via ad-hoc-news). One source gave 27 October, and Bloom's own announcement takes precedence.
On 13 October, Stocktwits reported that Oracle also proposed up to $55M a year in bill credits for New Mexico residential and small-business customers for up to three years. After the close, Oracle urged FERC to speed approval of the 17.8-mile Green Chile gas pipeline and warned that regulatory delay could push back the start of Project Jupiter (Investing.com via Yahoo Finance). That filing is described only in summary metadata, and the 14 October session will be the first to price it.
3. COMPANY PROFILE
Bloom Energy (Industrials, Electrical Equipment & Parts) designs, manufactures, sells and installs solid oxide fuel cell systems for on-site power. Its Energy Server converts natural gas, biogas, hydrogen or blends into electricity through a non-combustion electrochemical process, and it also offers an electrolyzer for hydrogen. Customers include utilities, data centers, retail, healthcare, education and telecom. The market cap is $77.59bn.
Recent results and guidance, all from Trefis (13 October):
- Q2 revenue was $1.065bn, up 166% year over year, which management called a record.
- On the 28 July call, management raised its 2026 adjusted operating income outlook to $800–900M from $425–450M and held adjusted gross margin at about 34%.
- Brookfield raised its financing commitment fivefold to $25bn in June 2026.
- Oracle's April 2026 expanded partnership covers up to 2.8 GW of fuel cells, and the stock rose about 23% the next day.
Project Jupiter covers up to 2.45 GW of Bloom capacity, replacing a gas-turbine and diesel design (Stocktwits). The earnings consensus is for EPS of 0.67 and revenue of $1.06bn.
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? The brief shows no deterioration in operations during the week. Guidance was raised in July, and Oracle said on 13 October that its plan is unchanged. The selling reflects valuation and positioning. The forward P/E is 53.5 and the trailing P/E 346.6, and the stock is up 166.95% year to date and 33.69% over 60 sessions, so a pre-earnings pullback fits that run. This is inference, supported by the pre-earnings de-risking cited by Investing.com.
Analyst stance. Targets are rising while the shares fall. UBS moved to $350, Barclays (Hold) to $308 and RBC (Outperform) holds $335. Bernstein sits at $282 with Market Perform. Roth (Neutral) raised its target from $225 to $260 and cited valuation and limited company transparency (Stocktwits, not verified against the note). The MarketBeat consensus average target of $258.32 was pulled before the Roth raise and sits below the $263.45 close, which supports the valuation-premium argument.
Peers. Over the same period VRT fell 6.26%, ETN 3.77% and ROK 4.09%, AME fell 1.28% and EMR rose 1.30%. The brief gives no sourced explanation for the wider electrical-equipment moves, though the data-center-exposed names fell most, which is consistent with the 8 October selloff in AI power names.
Comparable episodes. On 24 September Bloom fell more than 6% on reports that Oracle had invoked force majeure on Project Jupiter, which the company said remained on schedule, and it rebounded the next day without a fresh headline (Benzinga). On 28 September it fell 8.7% in the afternoon on the same concern, with a securities class action over Chinese-sourced scandium in the background (StockStory; Investing.com). The Jupiter gas pipeline has been delayed to February 2027 after permit setbacks (Benzinga). A Motley Fool headline says the stock has fallen 20% or more five times since September 2025 and recovered from four within weeks; the brief did not verify that count.
Bull case. Record Q2 revenue, sharply higher profit guidance, $25bn of Brookfield financing and Oracle's continued commitment to Bloom as primary power source. Analysts at UBS and RBC hold targets above the current price.
Bear case. Project Jupiter concentrates risk in one customer and depends on a pipeline that Oracle itself says faces regulatory delay. The valuation sits above the consensus target, Roth points to limited transparency, and the scandium class action remains in the background.
5. TECHNICAL SNAPSHOT
The $263.45 close sits above the 50-day average of $248.51 and the 200-day average of $214.14, so the longer trend remains intact despite the week's drop. The price is 25.0% below the 52-week high of $351.28 set on 25 June and far above the 52-week low of $75.70. The nearest support is the 12 October close of $262.28, just under the latest close, with the low of $248.35 on the last session and the 50-day average below that. The nearest resistance is $280.50, the 9 October close. Volume of 12,621,700 on the last session was 0.87x the 50-session average of 14,515,938, so the small rebound came on lighter participation than normal, while the two large down days on 8 and 12 October traded 15,754,600 and 14,031,900 shares.
6. RISK FACTORS
- Q3 results, 22 October after the close. Adjusted gross margin versus the roughly 34% guide is the figure Trefis identifies as key, alongside revenue against the $1.06bn estimate and EPS against 0.67.
- Project Jupiter timing. Oracle's FERC request on the Green Chile pipeline is pending, with no decision date found in the brief. The pipeline has already slipped to February 2027.
- Macro and rates. The 8 October selloff was linked to a 5.35% 10-year yield and Fed-hike worries, though only one source supports that.
- Legal. The securities class action over Chinese-sourced scandium is unresolved.
- Sentiment. Retail sentiment on Stocktwits turned bearish on 13 October; the brief treats this as anecdotal.
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks). The stock enters the 22 October report after a 10.93% weekly decline and with Oracle's pipeline warning not yet priced. The first read comes on 14 October. Support at $262.28 and resistance at $280.50 frame the range, and the earnings reaction will probably dominate both. In the past, drops tied to Jupiter headlines have partly reversed within days (24 September), which is the pattern to watch.
Medium term (1-3 months). The direction depends on gross margin holding near 34%, confirmation that the 2026 operating income outlook of $800–900M stands, and clarity on the pipeline schedule. Price targets from UBS ($350), RBC ($335) and Barclays ($308) sit above the current price, while Roth ($260), Bernstein ($282) and the consensus average ($258.32) sit near or below it, so the Street is split on how much is already priced in.
Long term. The thesis built on Oracle, Brookfield financing and data-center demand is unchanged by this week's evidence. The new information consists of price action and a pipeline delay that was already known. This is analysis only, not personal financial advice.